THE PETRIZZO GROUP, INC.

Lobbying for OMEROS CORPORATION · Pharmaceuticals

Filing Registration - Amendment

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Jul 21, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Washington

Lobbying activity 2

Health Issues

Issues involving the rare pediatric disease priority review voucher.

Medical/Disease Research/Clinical Labs

Issues involving the rare pediatric disease priority review voucher.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.